N-octyl-O-sulfate chitosan-modified liposomes for delivery of docetaxel: Preparation, characterization, and pharmacokinetics - 07/02/12
Corresponding authors.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 6 |
| Iconographies | 4 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
A N-octyl-O-sulfate chitosan (NOSC) anchored liposome system was developed as the carrier for antitumor drug, docetaxel (DTX). The physicochemical and pharmacokinetic properties of NOSC-modified DTX liposomes (NDLs) were evaluated compared with the conventional DTX liposomes (DLs) and commercial dosage form of DTX, Taxotere®. The results showed that NDLs had DTX-loading rate of 3.41%, entrapment efficiency of 61.73%, narrow distributed particle size of 147.6±1.9nm, and high zata potential of −44.2±3.9mV. The decreased permeability of the liposome bilayer was evaluated by release behavior of calcein (CAL) from the internal phase of NOSC-modified CAL liposomes (NCLs) and enhanced stability of NDLs owed to shielding effect of sulfonic shell from adsorption by BSA. After i.v. administration at the dose of 12mg/kg, a significant increase in the AUC, MRT, and T1/2β (P<0.05) was observed in NDLs group compared with DLs and Taxotere® group. AUC0–∞ of NDLs was 6.14 and 1.55 times higher than Taxotere® and DLs, respectively, and MRT0–∞ of NDLs was 5.77 and 1.37 times higher than Taxotere® and DLs, respectively. All these results suggested that anchored liposomes could increase the stability of DTX in vitro and in vivo, as compared with conventional liposomes and Taxotere®. Therefore, NOSC as a polymeric shell to liposomes was effective to enhance the stability of liposomes containing DTX.
Le texte complet de cet article est disponible en PDF.Keywords : Chitosan derivative anchored liposome, Docetaxel, Pharmacokinetics
Plan
Vol 66 - N° 1
P. 46-51 - février 2012 Retour au numéro
Article précédent
- Lung cancer alters the hydrolysis of nucleotides and nucleosides in platelets
- Daniela Zanini, Roberta Schmatz, Victor Camera Pimentel, Jessié Martins Gutierres, Paula Acosta Maldonado, Gustavo Roberto Thomé, Andréia Machado Cardoso, Naiara Stefanello, Liliane Oliveira, Juarez Chiesa, Daniela Bitencourt Rosa Leal, Vera Maria Morsch, Maria Rosa Chitolina Schetinger
- Propofol reduces MMPs expression by inhibiting NF-κB activity in human MDA-MB-231 cells
- Qing Li, Lei Zhang, Youqun Han, Zhen Jiang, Qingxiu Wang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?